{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T03:00:45Z","timestamp":1790910045600,"version":"4.1.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Microbiol"],"DOI":"10.1038\/s41564-025-02126-0","type":"journal-article","created":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T09:03:52Z","timestamp":1758877432000},"page":"2781-2796","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Epstein\u2013Barr virus exploits desmocollin 2 as the principal epithelial cell entry receptor"],"prefix":"10.1038","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4333-4436","authenticated-orcid":false,"given":"Hongbo","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zongjun","family":"Mou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7604-2296","authenticated-orcid":false,"given":"Yao Yu","family":"Yeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianyun","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8867-3669","authenticated-orcid":false,"given":"Yohei","family":"Narita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhixuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5964-1545","authenticated-orcid":false,"given":"Wanyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katelyn RS","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Bu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3965-3418","authenticated-orcid":false,"given":"Benjamin","family":"Gewurz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey I.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8536-8941","authenticated-orcid":false,"given":"Mingxiang","family":"Teng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4102-3175","authenticated-orcid":false,"given":"Xinghong","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuefeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6149-3142","authenticated-orcid":false,"given":"Sizun","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8612-5597","authenticated-orcid":false,"given":"Bo","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,26]]},"reference":[{"key":"2126_CR1","unstructured":"Gewurz, B. E., Longnecker, R. & Cohen, J. I. Epstein-Barr virus. in Fields Virology 7th edn (eds Knipe, D. & Howley, P.) 324\u2013389 (Wolters Kluwer, 2021."},{"key":"2126_CR2","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/S0140-6736(64)91524-7","volume":"1","author":"MA Epstein","year":"1964","unstructured":"Epstein, M. A., Achong, B. G. & Barr, Y. M. Virus particles in cultured lymphoblasts from Burkitt\u2019s lymphoma. Lancet 1, 702\u2013703 (1964).","journal-title":"Lancet"},{"key":"2126_CR3","doi-asserted-by":"crossref","first-page":"107fs107","DOI":"10.1126\/scitranslmed.3002878","volume":"3","author":"JI Cohen","year":"2011","unstructured":"Cohen, J. I., Fauci, A. S., Varmus, H. & Nabel, G. J. Epstein\u2013Barr virus: an important vaccine target for cancer prevention. Sci. Transl. Med. 3, 107fs107 (2011).","journal-title":"Sci. Transl. Med."},{"key":"2126_CR4","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s00432-021-03824-y","volume":"148","author":"Y Wong","year":"2022","unstructured":"Wong, Y., Meehan, M. T., Burrows, S. R., Doolan, D. L. & Miles, J. J. Estimating the global burden of Epstein\u2013Barr virus-related cancers. J. Cancer Res. Clin. Oncol. 148, 31\u201346 (2022).","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"2126_CR5","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1073\/pnas.59.1.94","volume":"59","author":"G Henle","year":"1968","unstructured":"Henle, G., Henle, W. & Diehl, V. Relation of Burkitt\u2019s tumor-associated herpes-type virus to infectious mononucleosis. Proc. Natl Acad. Sci. USA 59, 94\u2013101 (1968).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2126_CR6","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1093\/jnci\/92.18.1522","volume":"92","author":"H Hjalgrim","year":"2000","unstructured":"Hjalgrim, H. et al. Risk of Hodgkin\u2019s disease and other cancers after infectious mononucleosis. J. Natl Cancer Inst. 92, 1522\u20131528 (2000).","journal-title":"J. Natl Cancer Inst."},{"key":"2126_CR7","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/s41579-022-00770-5","volume":"21","author":"SS Soldan","year":"2023","unstructured":"Soldan, S. S. & Lieberman, P. M. Epstein\u2013Barr virus and multiple sclerosis. Nat. Rev. Microbiol. 21, 51\u201364 (2023).","journal-title":"Nat. Rev. Microbiol."},{"key":"2126_CR8","first-page":"160","volume":"19","author":"K Bjornevik","year":"2023","unstructured":"Bjornevik, K., Munz, C., Cohen, J. I. & Ascherio, A. Epstein\u2013Barr virus as a leading cause of multiple sclerosis: mechanisms and implications. Nat. Rev. Neurol. 19, 160\u2013171 (2023).","journal-title":"Nat. Rev. Neurol."},{"key":"2126_CR9","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1126\/science.abj8222","volume":"375","author":"K Bjornevik","year":"2022","unstructured":"Bjornevik, K. et al. Longitudinal analysis reveals high prevalence of Epstein\u2013Barr virus associated with multiple sclerosis. Science 375, 296\u2013301 (2022).","journal-title":"Science"},{"key":"2126_CR10","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/s41586-022-04432-7","volume":"603","author":"TV Lanz","year":"2022","unstructured":"Lanz, T. V. et al. Clonally expanded B cells in multiple sclerosis bind EBV EBNA1 and GlialCAM. Nature 603, 321\u2013327 (2022).","journal-title":"Nature"},{"key":"2126_CR11","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1084\/jem.20071030","volume":"204","author":"B Serafini","year":"2007","unstructured":"Serafini, B. et al. Dysregulated Epstein\u2013Barr virus infection in the multiple sclerosis brain. J. Exp. Med. 204, 2899\u20132912 (2007).","journal-title":"J. Exp. Med."},{"key":"2126_CR12","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1177\/13524585241237707","volume":"30","author":"R Goldacre","year":"2024","unstructured":"Goldacre, R. Risk of multiple sclerosis in individuals with infectious mononucleosis: a national population-based cohort study using hospital records in England, 2003\u20132023. Mult. Scler. 30, 489\u2013495 (2024).","journal-title":"Mult. Scler."},{"key":"2126_CR13","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/s41588-018-0102-3","volume":"50","author":"JB Harley","year":"2018","unstructured":"Harley, J. B. et al. Transcription factors operate across disease loci, with EBNA2 implicated in autoimmunity. Nat. Genet. 50, 699\u2013707 (2018).","journal-title":"Nat. Genet."},{"key":"2126_CR14","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/bs.aivir.2019.05.006","volume":"104","author":"BS Mohl","year":"2019","unstructured":"Mohl, B. S., Chen, J. & Longnecker, R. Gammaherpesvirus entry and fusion: a tale how two human pathogenic viruses enter their host cells. Adv. Virus Res. 104, 313\u2013343 (2019).","journal-title":"Adv. Virus Res."},{"key":"2126_CR15","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/s41579-020-00448-w","volume":"19","author":"SA Connolly","year":"2021","unstructured":"Connolly, S. A., Jardetzky, T. S. & Longnecker, R. The structural basis of herpesvirus entry. Nat. Rev. Microbiol. 19, 110\u2013121 (2021).","journal-title":"Nat. Rev. Microbiol."},{"key":"2126_CR16","doi-asserted-by":"crossref","first-page":"7825","DOI":"10.1128\/JVI.00445-07","volume":"81","author":"LM Hutt-Fletcher","year":"2007","unstructured":"Hutt-Fletcher, L. M. Epstein\u2013Barr virus entry. J. Virol. 81, 7825\u20137832 (2007).","journal-title":"J. Virol."},{"key":"2126_CR17","doi-asserted-by":"crossref","first-page":"4657","DOI":"10.1128\/jvi.71.6.4657-4662.1997","volume":"71","author":"Q Li","year":"1997","unstructured":"Li, Q. et al. Epstein\u2013Barr virus uses HLA class II as a cofactor for infection of B lymphocytes. J. Virol. 71, 4657\u20134662 (1997).","journal-title":"J. Virol."},{"key":"2126_CR18","doi-asserted-by":"crossref","first-page":"5552","DOI":"10.1128\/JVI.72.7.5552-5558.1998","volume":"72","author":"X Wang","year":"1998","unstructured":"Wang, X., Kenyon, W. J., Li, Q., Mullberg, J. & Hutt-Fletcher, L. M. Epstein\u2013Barr virus uses different complexes of glycoproteins gH and gL to infect B lymphocytes and epithelial cells. J. Virol. 72, 5552\u20135558 (1998).","journal-title":"J. Virol."},{"key":"2126_CR19","doi-asserted-by":"crossref","first-page":"11036","DOI":"10.1073\/pnas.1513359112","volume":"112","author":"D Xiong","year":"2015","unstructured":"Xiong, D. et al. Nonmuscle myosin heavy chain IIA mediates Epstein\u2013Barr virus infection of nasopharyngeal epithelial cells. Proc. Natl Acad. Sci. USA 112, 11036\u201311041 (2015).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2126_CR20","volume":"6","author":"HB Wang","year":"2015","unstructured":"Wang, H. B. et al. Neuropilin 1 is an entry factor that promotes EBV infection of nasopharyngeal epithelial cells. Nat. Commun. 6, 6240 (2015).","journal-title":"Nat. Commun."},{"key":"2126_CR21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41564-017-0080-8","volume":"3","author":"H Zhang","year":"2018","unstructured":"Zhang, H. et al. Ephrin receptor A2 is an epithelial cell receptor for Epstein\u2013Barr virus entry. Nat. Microbiol. 3, 1\u20138 (2018).","journal-title":"Nat. Microbiol."},{"key":"2126_CR22","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/s41564-017-0081-7","volume":"3","author":"J Chen","year":"2018","unstructured":"Chen, J. et al. Ephrin receptor A2 is a functional entry receptor for Epstein\u2013Barr virus. Nat. Microbiol. 3, 172\u2013180 (2018).","journal-title":"Nat. Microbiol."},{"key":"2126_CR23","doi-asserted-by":"crossref","first-page":"4371","DOI":"10.1128\/JVI.72.5.4371-4378.1998","volume":"72","author":"S Imai","year":"1998","unstructured":"Imai, S., Nishikawa, J. & Takada, K. Cell-to-cell contact as an efficient mode of Epstein\u2013Barr virus infection of diverse human epithelial cells. J. Virol. 72, 4371\u20134378 (1998).","journal-title":"J. Virol."},{"key":"2126_CR24","doi-asserted-by":"crossref","first-page":"7065","DOI":"10.1073\/pnas.0510512103","volume":"103","author":"CD Shannon-Lowe","year":"2006","unstructured":"Shannon-Lowe, C. D., Neuhierl, B., Baldwin, G., Rickinson, A. B. & Delecluse, H. J. Resting B cells as a transfer vehicle for Epstein\u2013Barr virus infection of epithelial cells. Proc. Natl Acad. Sci. USA 103, 7065\u20137070 (2006).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2126_CR25","doi-asserted-by":"crossref","first-page":"2989","DOI":"10.1099\/jgv.0.000605","volume":"97","author":"A Nanbo","year":"2016","unstructured":"Nanbo, A., Kachi, K., Yoshiyama, H. & Ohba, Y. Epstein\u2013Barr virus exploits host endocytic machinery for cell-to-cell viral transmission rather than a virological synapse. J. Gen. Virol. 97, 2989\u20133006 (2016).","journal-title":"J. Gen. Virol."},{"key":"2126_CR26","doi-asserted-by":"crossref","first-page":"9285","DOI":"10.1128\/JVI.00712-12","volume":"86","author":"A Nanbo","year":"2012","unstructured":"Nanbo, A., Terada, H., Kachi, K., Takada, K. & Matsuda, T. Roles of cell signaling pathways in cell-to-cell contact-mediated Epstein\u2013Barr virus transmission. J. Virol. 86, 9285\u20139296 (2012).","journal-title":"J. Virol."},{"key":"2126_CR27","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1086\/523813","volume":"196","author":"EM Sokal","year":"2007","unstructured":"Sokal, E. M. et al. Recombinant gp350 vaccine for infectious mononucleosis: a phase 2, randomized, double-blind, placebo-controlled trial to evaluate the safety, immunogenicity, and efficacy of an Epstein\u2013Barr virus vaccine in healthy young adults. J. Infect. Dis. 196, 1749\u20131753 (2007).","journal-title":"J. Infect. Dis."},{"key":"2126_CR28","doi-asserted-by":"crossref","first-page":"4697","DOI":"10.1016\/j.vaccine.2007.04.008","volume":"25","author":"M Moutschen","year":"2007","unstructured":"Moutschen, M. et al. Phase I\/II studies to evaluate safety and immunogenicity of a recombinant gp350 Epstein\u2013Barr virus vaccine in healthy adults. Vaccine 25, 4697\u20134705 (2007).","journal-title":"Vaccine"},{"key":"2126_CR29","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.cell.2015.07.043","volume":"162","author":"M Kanekiyo","year":"2015","unstructured":"Kanekiyo, M. et al. Rational design of an Epstein\u2013Barr virus vaccine targeting the receptor-binding site. Cell 162, 1090\u20131100 (2015).","journal-title":"Cell"},{"key":"2126_CR30","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.immuni.2024.02.008","volume":"57","author":"W Bu","year":"2024","unstructured":"Bu, W. et al. Epstein\u2013Barr virus gp42 antibodies reveal sites of vulnerability for receptor binding and fusion to B cells. Immunity 57, 559\u2013573.e6 (2024).","journal-title":"Immunity"},{"key":"2126_CR31","volume":"14","author":"CJ Wei","year":"2022","unstructured":"Wei, C. J. et al. A bivalent Epstein\u2013Barr virus vaccine induces neutralizing antibodies that block infection and confer immunity in humanized mice. Sci. Transl. Med. 14, eabf3685 (2022).","journal-title":"Sci. Transl. Med."},{"key":"2126_CR32","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1016\/j.chom.2023.09.011","volume":"31","author":"C Sun","year":"2023","unstructured":"Sun, C. et al. A gB nanoparticle vaccine elicits a protective neutralizing antibody response against EBV. Cell Host Microbe 31, 1882\u20131897.e10 (2023).","journal-title":"Cell Host Microbe"},{"key":"2126_CR33","volume":"15","author":"W Li","year":"2014","unstructured":"Li, W. et al. MAGeCK enables robust identification of essential genes from genome-scale CRISPR\/Cas9 knockout screens. Genome Biol. 15, 554 (2014).","journal-title":"Genome Biol."},{"key":"2126_CR34","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1099\/vir.0.007237-0","volume":"90","author":"J Sorem","year":"2009","unstructured":"Sorem, J. & Longnecker, R. Cleavage of Epstein\u2013Barr virus glycoprotein B is required for full function in cell\u2013cell fusion with both epithelial and B cells. J. Gen. Virol. 90, 591\u2013595 (2009).","journal-title":"J. Gen. Virol."},{"key":"2126_CR35","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1016\/j.immuni.2022.10.003","volume":"55","author":"WH Chen","year":"2022","unstructured":"Chen, W. H. et al. Epstein\u2013Barr virus gH\/gL has multiple sites of vulnerability for virus neutralization and fusion inhibition. Immunity 55, 2135\u20132148.e6 (2022).","journal-title":"Immunity"},{"key":"2126_CR36","doi-asserted-by":"crossref","first-page":"e01255-17","DOI":"10.1128\/JVI.01255-17","volume":"91","author":"BS Mohl","year":"2017","unstructured":"Mohl, B. S., Chen, J., Park, S. J., Jardetzky, T. S. & Longnecker, R. Epstein\u2013Barr virus fusion with epithelial cells triggered by gB is restricted by a gL glycosylation site. J. Virol. 91, e01255-17 (2017).","journal-title":"J. Virol."},{"key":"2126_CR37","doi-asserted-by":"crossref","first-page":"22641","DOI":"10.1073\/pnas.1011806108","volume":"107","author":"H Matsuura","year":"2010","unstructured":"Matsuura, H., Kirschner, A. N., Longnecker, R. & Jardetzky, T. S. Crystal structure of the Epstein\u2013Barr virus (EBV) glycoprotein H\/glycoprotein L (gH\/gL) complex. Proc. Natl Acad. Sci. USA 107, 22641\u201322646 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2126_CR38","doi-asserted-by":"crossref","first-page":"D886","DOI":"10.1093\/nar\/gkae1142","volume":"53","author":"CZICS Program","year":"2025","unstructured":"Program, C. Z. I. C. S. et al. CZ CELLxGENE Discover: a single-cell data platform for scalable exploration, analysis and modeling of aggregated data. Nucleic Acids Res. 53, D886\u2013D900 (2025).","journal-title":"Nucleic Acids Res."},{"key":"2126_CR39","doi-asserted-by":"crossref","first-page":"eaan2507","DOI":"10.1126\/science.aan2507","volume":"357","author":"M Uhlen","year":"2017","unstructured":"Uhlen, M. et al. A pathology atlas of the human cancer transcriptome. Science 357, eaan2507 (2017).","journal-title":"Science"},{"key":"2126_CR40","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/nm.2270","volume":"17","author":"H Wang","year":"2011","unstructured":"Wang, H. et al. Desmoglein 2 is a receptor for adenovirus serotypes 3, 7, 11 and 14. Nat. Med. 17, 96\u2013104 (2011).","journal-title":"Nat. Med."},{"key":"2126_CR41","volume":"11","author":"C Su","year":"2020","unstructured":"Su, C. et al. Molecular basis of EphA2 recognition by gHgL from gammaherpesviruses. Nat. Commun. 11, 5964 (2020).","journal-title":"Nat. Commun."},{"key":"2126_CR42","volume":"12","author":"QY Zhu","year":"2021","unstructured":"Zhu, Q. Y. et al. A potent and protective human neutralizing antibody targeting a novel vulnerable site of Epstein\u2013Barr virus. Nat. Commun. 12, 6624 (2021).","journal-title":"Nat. Commun."},{"key":"2126_CR43","doi-asserted-by":"crossref","first-page":"e1009210","DOI":"10.1371\/journal.ppat.1009210","volume":"17","author":"N Wallaschek","year":"2021","unstructured":"Wallaschek, N. et al. Ephrin receptor A2, the epithelial receptor for Epstein\u2013Barr virus entry, is not available for efficient infection in human gastric organoids. PLoS Pathog. 17, e1009210 (2021).","journal-title":"PLoS Pathog."},{"key":"2126_CR44","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.molcel.2020.03.025","volume":"78","author":"R Guo","year":"2020","unstructured":"Guo, R. et al. MYC controls the Epstein\u2013Barr virus lytic switch. Mol. Cell 78, 653\u2013669.e8 (2020).","journal-title":"Mol. Cell"},{"key":"2126_CR45","first-page":"e00513","volume":"93","author":"C Wang","year":"2019","unstructured":"Wang, C. et al. TAF family proteins and MEF2C are essential for Epstein\u2013Barr virus super-enhancer activity. J. Virol. 93, e00513\u2013e00519 (2019).","journal-title":"J. Virol."},{"key":"2126_CR46","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1128\/JVI.06314-11","volume":"86","author":"M Kalla","year":"2012","unstructured":"Kalla, M., Gobel, C. & Hammerschmidt, W. The lytic phase of Epstein\u2013Barr virus requires a viral genome with 5-methylcytosine residues in CpG sites. J. Virol. 86, 447\u2013458 (2012).","journal-title":"J. Virol."},{"key":"2126_CR47","first-page":"e3168","volume":"53","author":"S Zhang","year":"2011","unstructured":"Zhang, S., Tan, H.C. & Ooi, E.E. Visualizing dengue virus through Alexa Fluor labeling. J. Vis. Exp. 53, e3168 (2011).","journal-title":"J. Vis. Exp."},{"key":"2126_CR48","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1002\/jmv.26093","volume":"92","author":"X Liu","year":"2020","unstructured":"Liu, X. & Mondal, A. M. Conditional cell reprogramming for modeling host\u2013virus interactions and human viral diseases. J. Med. Virol. 92, 2440\u20132452 (2020).","journal-title":"J. Med. Virol."},{"key":"2126_CR49","doi-asserted-by":"crossref","first-page":"22741","DOI":"10.18632\/oncotarget.13937","volume":"8","author":"OA Timofeeva","year":"2017","unstructured":"Timofeeva, O. A. et al. Conditionally reprogrammed normal and primary tumor prostate epithelial cells: a novel patient-derived cell model for studies of human prostate cancer. Oncotarget 8, 22741\u201322758 (2017).","journal-title":"Oncotarget"},{"key":"2126_CR50","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1002\/(SICI)1521-186X(1996)17:6<450::AID-BEM4>3.0.CO;2-2","volume":"17","author":"R Goldman","year":"1996","unstructured":"Goldman, R. & Pollack, S. Electric fields and proliferation in a chronic wound model. Bioelectromagnetics 17, 450\u2013457 (1996).","journal-title":"Bioelectromagnetics"},{"key":"2126_CR51","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.chom.2019.04.003","volume":"25","author":"G Bajic","year":"2019","unstructured":"Bajic, G. et al. Influenza antigen engineering focuses immune responses to a subdominant but broadly protective viral epitope. Cell Host Microbe 25, 827\u2013835.e6 (2019).","journal-title":"Cell Host Microbe"},{"key":"2126_CR52","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1016\/j.cell.2021.03.027","volume":"184","author":"SA Clark","year":"2021","unstructured":"Clark, S. A. et al. SARS-CoV-2 evolution in an immunocompromised host reveals shared neutralization escape mechanisms. Cell 184, 2605\u20132617.e18 (2021).","journal-title":"Cell"},{"key":"2126_CR53","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.bbrc.2022.01.056","volume":"594","author":"W Guo","year":"2022","unstructured":"Guo, W., Wang, M. & Chen, L. A co-expression vector for baculovirus-mediated protein expression in mammalian cells. Biochem. Biophys. Res. Commun. 594, 69\u201373 (2022).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"2126_CR54","doi-asserted-by":"crossref","first-page":"e43","DOI":"10.1093\/nar\/gkm067","volume":"35","author":"C Scheich","year":"2007","unstructured":"Scheich, C., Kummel, D., Soumailakakis, D., Heinemann, U. & Bussow, K. Vectors for co-expression of an unrestricted number of proteins. Nucleic Acids Res. 35, e43 (2007).","journal-title":"Nucleic Acids Res."}],"container-title":["Nature Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41564-025-02126-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41564-025-02126-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41564-025-02126-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T22:23:24Z","timestamp":1761949404000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41564-025-02126-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,26]]},"references-count":54,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025,11]]}},"alternative-id":["2126"],"URL":"https:\/\/doi.org\/10.1038\/s41564-025-02126-0","relation":{},"ISSN":["2058-5276"],"issn-type":[{"value":"2058-5276","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,26]]},"assertion":[{"value":"7 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"S.J. is a co-founder of Elucidate Bio Inc. and has received research support from Roche and Novartis, both unrelated to this work. All other authors declare that they have no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}